Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

Nicklas J. Johansen; Thomas F. Dejgaard; Asger Lund; Camilla Schluntz; Christian S. Frandsen; Julie L. Forman; Nicolai J. Wewer Albrechtsen; Jens J. Holst; Ulrik Pedersen-Bjergaard; Sten Madsbad; Tina Vilsbøll; Henrik U. Andersen; Filip K. Knop

doi:10.1016/S2213-8587(20)30030-9

Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

Nicklas J. Johansen, Thomas F. Dejgaard, Asger Lund, Camilla Schluntz, Christian S. Frandsen, Julie L. Forman, Nicolai J. Wewer Albrechtsen, Jens J. Holst, Ulrik Pedersen-Bjergaard, Sten Madsbad, Tina Vilsbøll, Henrik U. Andersen, Filip K. Knop

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

52 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	The Lancet Diabetes & Endocrinology
Vol/bind	8
Udgave nummer	4
Sider (fra-til)	313-324
Antal sider	12
ISSN	2213-8587
DOI	https://doi.org/10.1016/S2213-8587(20)30030-9
Status	Udgivet - 2020

Adgang til dokumentet

10.1016/S2213-8587(20)30030-9

Citationsformater

Johansen, N. J., Dejgaard, T. F., Lund, A., Schluntz, C., Frandsen, C. S., Forman, J. L., Albrechtsen, N. J. W., Holst, J. J., Pedersen-Bjergaard, U., Madsbad, S., Vilsbøll, T., Andersen, H. U., & Knop, F. K. (2020). Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial. The Lancet Diabetes & Endocrinology, 8(4), 313-324. https://doi.org/10.1016/S2213-8587(20)30030-9

Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial. / Johansen, Nicklas J.; Dejgaard, Thomas F.; Lund, Asger et al.
I: The Lancet Diabetes & Endocrinology, Bind 8, Nr. 4, 2020, s. 313-324.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Johansen, NJ, Dejgaard, TF, Lund, A, Schluntz, C, Frandsen, CS, Forman, JL , Albrechtsen, NJW , Holst, JJ , Pedersen-Bjergaard, U , Madsbad, S , Vilsbøll, T, Andersen, HU & Knop, FK 2020, 'Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial', The Lancet Diabetes & Endocrinology, bind 8, nr. 4, s. 313-324. https://doi.org/10.1016/S2213-8587(20)30030-9

@article{ac533e4fcae94f4c9edbe53aef06af03,

title = "Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial",

author = "Johansen, {Nicklas J.} and Dejgaard, {Thomas F.} and Asger Lund and Camilla Schluntz and Frandsen, {Christian S.} and Forman, {Julie L.} and Albrechtsen, {Nicolai J. Wewer} and Holst, {Jens J.} and Ulrik Pedersen-Bjergaard and Sten Madsbad and Tina Vilsb{\o}ll and Andersen, {Henrik U.} and Knop, {Filip K.}",

year = "2020",

doi = "10.1016/S2213-8587(20)30030-9",

language = "English",

volume = "8",

pages = "313--324",

journal = "The Lancet Diabetes & Endocrinology",

issn = "2213-8587",

publisher = "The Lancet Publishing Group",

number = "4",

}

TY - JOUR

T1 - Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C)

T2 - a randomised, double-blind, placebo-controlled trial

AU - Johansen, Nicklas J.

AU - Dejgaard, Thomas F.

AU - Lund, Asger

AU - Schluntz, Camilla

AU - Frandsen, Christian S.

AU - Forman, Julie L.

AU - Albrechtsen, Nicolai J. Wewer

AU - Holst, Jens J.

AU - Pedersen-Bjergaard, Ulrik

AU - Madsbad, Sten

AU - Vilsbøll, Tina

AU - Andersen, Henrik U.

AU - Knop, Filip K.

PY - 2020

Y1 - 2020

U2 - 10.1016/S2213-8587(20)30030-9

DO - 10.1016/S2213-8587(20)30030-9

M3 - Journal article

SN - 2213-8587

VL - 8

SP - 313

EP - 324

JO - The Lancet Diabetes & Endocrinology

JF - The Lancet Diabetes & Endocrinology

IS - 4

ER -